Meta-analysis  	Meta-analysis  	 JJ	B-NP
of  	of  	 IN	O
medical  	medical  	 JJ	O
and  	and  	 CC	O
non-medical  	non-medical  	 JJ	B-NP
treatments  	treatments  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
prodromal  	prodromal  	 JJ	I-NP
phase  	phase  	 NN	I-NP
of  	of  	 IN	I-NP
psychotic  	psychotic  	 JJ	I-NP
illness  	illness  	 NN	I-NP
in  	in  	 IN	O
at-risk  	at-risk  	 JJ	B-NP
mental  	mental  	 JJ	I-NP
states  	states  	 NNS	I-NP
there  	there  	 EX	O
are  	are  	 VBP	O
now  	now  	 RB	O
many  	many  	 JJ	O
existing  	existing  	 JJ	O
studies  	studies  	 NNS	O
which  	which  	 WDT	O
assess  	assess  	 VBP	O
the  	the  	 DT	O
treatments  	treatments  	 JJ	O
available  	available  	 JJ	O
for  	for  	 IN	O
' 	' 	 ''	O
at  	at  	 IN	O
risk  	risk  	 NN	O
mental  	mental  	 JJ	B-NP
states 	states 	 NNS	I-NP
' 	' 	 POS	O
,  	,  	 ,	O
as  	as  	 IN	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
are  	are  	 VBP	O
believed  	believed  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
prodromal  	prodromal  	 JJ	B-NP
phase  	phase  	 NN	I-NP
of  	of  	 IN	I-NP
psychotic  	psychotic  	 JJ	I-NP
illness  	illness  	 NNS	I-NP
are  	are  	 VBP	O
referred  	referred  	 VBN	O
to 	to 	 TO	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
concerns  	concerns  	 NNS	O
regarding  	regarding  	 VBG	B-NP
side  	side  	 NN	I-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	O
possible  	possible  	 JJ	O
treatments  	treatments  	 NNS	O
remain 	remain 	 VBP	O
.  	.  	 .	O
We  	We  	 PRP	O
here  	here  	 RB	O
conduct  	conduct  	 VB	O
a  	a  	 DT	O
meta-analysis  	meta-analysis  	 JJ	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
studies  	studies  	 NNS	O
available  	available  	 VBP	O
up  	up  	 RP	O
to  	to  	 TO	O
October  	October  	 NNP	O
2010 	2010 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
aim  	aim  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
is  	is  	 VBZ	O
to  	to  	 TO	O
decide  	decide  	 VB	O
what  	what  	 WP	O
would  	would  	 MD	O
be  	be  	 VB	O
the  	the  	 DT	O
best  	best  	 JJS	O
treatment  	treatment  	 NN	O
for  	for  	 IN	O
' 	' 	 ''	O
at  	at  	 IN	O
high  	high  	 JJ	O
risk  	risk  	 NN	B-NP
patients 	patients 	 NNS	I-NP
' 	' 	 POS	O
.  	.  	 .	O
all  	all  	 PDT	O
the  	the  	 DT	O
available  	available  	 JJ	O
studies  	studies  	 NNS	O
examining  	examining  	 VBG	O
potential  	potential  	 JJ	B-NP
treatments  	treatments  	 NNS	I-NP
during  	during  	 IN	O
the  	the  	 DT	O
prodromal  	prodromal  	 JJ	B-NP
phase  	phase  	 NN	I-NP
of  	of  	 IN	I-NP
psychotic  	psychotic  	 JJ	I-NP
illness  	illness  	 NN	I-NP
were  	were  	 VBD	O
collected 	collected 	 VBN	O
.  	.  	 .	O
They  	They  	 PRP	O
all  	all  	 RB	O
showed  	showed  	 VBD	O
comparable  	comparable  	 JJ	O
efficacy 	efficacy 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
reached  	reached  	 VBD	O
statistical  	statistical  	 JJ	B-NP
significance 	significance 	 NN	I-NP
,  	,  	 ,	O
excluding  	excluding  	 VBG	O
the  	the  	 DT	O
one  	one  	 CD	O
study  	study  	 NN	O
using  	using  	 VBG	O
olanzapine 	olanzapine 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
in  	in  	 IN	O
fact  	fact  	 NN	O
' 	' 	 POS	O
tended  	tended  	 NN	O
towards  	towards  	 IN	O
significance 	significance 	 NN	B-NP
' 	' 	 POS	O
.  	.  	 CD	O
treatments  	treatments  	 NNS	O
appear  	appear  	 VBP	O
promising  	promising  	 VBG	O
but  	but  	 CC	O
a  	a  	 DT	O
balance  	balance  	 NN	O
needs  	needs  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
kept  	kept  	 VBN	O
between  	between  	 IN	O
adverse  	adverse  	 JJ	O
events  	events  	 NNS	O
and  	and  	 CC	O
effectiveness  	effectiveness  	 NN	O
of  	of  	 IN	O
preventing  	preventing  	 VBG	B-NP
psychosis.  	psychosis.  	 NN	I-NP
it  	it  	 PRP	O
is  	is  	 VBZ	O
necessary  	necessary  	 JJ	O
to  	to  	 TO	O
search  	search  	 VB	O
further  	further  	 RBR	O
for  	for  	 IN	O
treatments  	treatments  	 NNS	O
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
identify  	identify  	 VB	O
effective  	effective  	 JJ	O
treatments  	treatments  	 NNS	O
with  	with  	 IN	O
fewer  	fewer  	 JJR	O
adverse  	adverse  	 JJ	O
side  	side  	 NN	B-NP
effects  	effects  	 NNS	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
phase  	phase  	 NN	O
of  	of  	 IN	O
psychotic  	psychotic  	 JJ	B-NP
illness 	illness 	 NN	I-NP
.  	.  	 .	O
